Embedded biosensors for on-site diagnostics and remote patient monitoring
Grapheal develops wearable and disposable biosensors enabling continuous monitoring and on-site diagnosis. It empowers caregivers with an improved and individualized assessment tool for precision medicine.
BRINGING THE FUTURE OF DATA-DRIVEN WOUND CARE
More than 6.5 million persons are suffering from chronic wounds in the United States. The cost and incidence of chronic wounds is increasing, due to the aging population, and the increased prevalence of diabetes.
New treatments for chronic wounds have led to improvements in wound management but wound monitoring tools and methodologies have not kept pace with this progress. Wound assessment is complex and requires a range of clinical skills and knowledge.
That is why wound care at home is expensive and often innefficient given that care providers simply do not have the necessary tools to accurately track wound healing over time.
415 million people suffer from diabetes worldwide
25% will develop a chronic wound (Diabetic Foot Ulcer)
500,000 amputations each year are caused by DFU complications
The estimated US healthcare cost of DFU is $13 billion/year
GRAPHENE TECHNOLOGY UNLOCKS THE INTERNET OF FIELD DIAGNOSTICS
Grapheal devices are based on Graphene, an innovative material that has been touted as the "miracle material" of the 21st Century.
Graphene forms an ultra-thin layer (one atom thick) of pure crystalline carbon. Graphene sits at the border between inorganic (think microelectronics) and organic (think biology) worlds. It efficiently bridges these two fields which usually exclude each other, creating a "bio-electronics" platform capable of sensing & digitizing biochemical signals right where they occur.
REMOTE MONITORING OF HEALING
Grapheal presents an electronic wound patch that continuously measures and stores wound biometric parameters, and communicates them to a medical cloud via a smartphone app.
Thus, doctors and nurses can monitor the wound healing evolution remotely and be alerted of any early-stage infection, and prevent complications. Grapheal patches will make any bandage smart & connected.
Graphene forms an ultrathin and robust conductive layer.
Our patented method of integration on polymer produces soft flexible and fully biocompatible electrodes.
Biocompatible and non-invasive sensors
Ultrasensitive response to biofilm and body fluid compositions
Multiparametered, multi plexed detection
Flexible, breathable and transparent
Low cost wearable electronics
Cloud-connected data analysis
Grapheal was created in the spring of 2019 as a spin-off from the Institut Néel of the CNRS in Grenoble, that is one of the largest condensed matter physics labs in Europe.
The startup valorises the knowledge and technologies developed over the past ten years by the research team of Dr. Vincent Bouchiat, the CEO and co-founder of Grapheal.
We are a multidisciplinary team with a passion for technology for healthcare, and expertise in material sciences, biochemistry, wireless electronics, cloud, and software engineering.